Pharmacokinetics and effects of isoxicam on renal function in patients with renal insufficiency. 1986

P M Brooks, and M McCredie, and M Prowse, and M Podgorski, and M Forrest, and I Munro, and J Boutagy, and L Pei-Ling

The pharmacokinetics of isoxicam, a new non-steroidal anti-inflammatory drug, were studied in 20 osteoarthritis patients with varying degrees of renal insufficiency. A wide variation in pharmacokinetic parameters was seen between individuals but there was no suggestion that renal function influenced pharmacokinetics. Steady state plasma isoxicam concentrations varied from 20 micrograms/ml to 130 micrograms/ml, while the plasma half-life varied from 23 hours to 58 hours. Despite a reduction in urinary prostaglandin E2 excretion, isoxicam administration did not alter renal function over a 4-week period.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010894 Piroxicam A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily. CP-16171,Feldene,CP 16171,CP16171
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents

Related Publications

P M Brooks, and M McCredie, and M Prowse, and M Podgorski, and M Forrest, and I Munro, and J Boutagy, and L Pei-Ling
April 1985, The British journal of clinical practice,
P M Brooks, and M McCredie, and M Prowse, and M Podgorski, and M Forrest, and I Munro, and J Boutagy, and L Pei-Ling
April 1992, British journal of clinical pharmacology,
P M Brooks, and M McCredie, and M Prowse, and M Podgorski, and M Forrest, and I Munro, and J Boutagy, and L Pei-Ling
January 1976, Therapie,
P M Brooks, and M McCredie, and M Prowse, and M Podgorski, and M Forrest, and I Munro, and J Boutagy, and L Pei-Ling
January 1983, European journal of clinical pharmacology,
P M Brooks, and M McCredie, and M Prowse, and M Podgorski, and M Forrest, and I Munro, and J Boutagy, and L Pei-Ling
September 1984, Antimicrobial agents and chemotherapy,
P M Brooks, and M McCredie, and M Prowse, and M Podgorski, and M Forrest, and I Munro, and J Boutagy, and L Pei-Ling
September 1982, The Journal of antimicrobial chemotherapy,
P M Brooks, and M McCredie, and M Prowse, and M Podgorski, and M Forrest, and I Munro, and J Boutagy, and L Pei-Ling
January 1986, Antimicrobial agents and chemotherapy,
P M Brooks, and M McCredie, and M Prowse, and M Podgorski, and M Forrest, and I Munro, and J Boutagy, and L Pei-Ling
April 1990, Journal of clinical pharmacology,
P M Brooks, and M McCredie, and M Prowse, and M Podgorski, and M Forrest, and I Munro, and J Boutagy, and L Pei-Ling
January 1999, British journal of clinical pharmacology,
P M Brooks, and M McCredie, and M Prowse, and M Podgorski, and M Forrest, and I Munro, and J Boutagy, and L Pei-Ling
February 1984, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!